http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0753378-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba045776bcd32d32e3100da8dfce4e28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16f935ea6cb9c8927f7e3255aa283c62 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate | 1994-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fac2682512be34b01a76c42e64e557 |
| publicationDate | 1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0753378-A |
| titleOfInvention | Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them for use in leukotriene-mediated diseases or conditions |
| abstract | (57) [Summary] [Purpose] A novel thiazole derivative which can be used as an inhibitor of 5-LO. [In the formula, Q is 2-oxo-1,2,3,4-tetrahydroquinolin-6-yl or 2-oxo-1,2-dihydroquinolin-6-yl; these are C at the 1-position nitrogen atom. Has 1 -C 4 alkyl substituents, X 1 is thio, sulphinyl or sulphonyl; is Ar thiazolediyl;, R 1 is C 1 -C 4 alkyl, C 3 -C 4 alkenyl or C 3 -C 4 Alkynyl; R 2 and R 3 taken together form a group of the formula: —A 2 —X 2 —A 3 —, which group is A 2 And A 3 together with the carbon atom to which they are attached represent a ring having a 5- or 6-membered ring atom, wherein A 2 and A 3 may be the same or different and each is C 1 -C 3 alkylene. X 2 represents oxy, and the ring has 1 or 2 C 1 -C 4 alkyl substituents], or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006527207-A |
| priorityDate | 1993-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.